Flash FinanceUS
Pre-market S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI filing briefs · archive

8-K filings in June 2024, explained

109 material Form 8-K filings that 99 companies we cover made with the SEC in June 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

1 of 109 briefs matches

newest first · times in ET
TGTXTG THERAPEUTICS, INC. Jun 17, 4:48 PM ET

TG Therapeutics shareholders approve increase in authorized common shares to 190 million

Mixed shareholder Written later 5.025.035.07

At its June 14, 2024 annual meeting, TG Therapeutics stockholders approved raising authorized common stock from 175,000,000 to 190,000,000 shares and removing the full-value awards limit in the 2022 Incentive Plan. The company filed the charter amendment the same day, and all five proposals passed, although three director nominees received less than half of the votes cast for them. The larger share authorization gives the company room to issue more common stock, which could dilute existing holders.

  • Authorized common shares rise from 175,000,000 to 190,000,000; 73,780,225 votes for, 36,348,764 against, 946,040 abstentions.
  • 2022 Incentive Plan amendment removing the full-value awards limit passed with 66,744,142 votes for and 8,625,685 against.
  • Advisory say-on-pay vote: 42,346,581 for, 31,019,084 against, 2,748,761 abstentions.
  • Yann Echelard (46.05%), Daniel Hume (46.03%) and Sagar Lonial, MD (43.75%) each received less than half of votes cast for them.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.